2021 IPO, Venture Capital and M&A Reports

  • 4.26.2021

WilmerHale’s annual IPO, Venture Capital and M&A Reports insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

The 2021 IPO Report a detailed IPO market review and outlook, plus useful market metrics and articles on topics of interest for pre-IPO companies, including:

  • The resilience of the IPO market in the face of the COVID-19 pandemic
  • The impact of the on capital formation almost ten years on
  • Direct listing as an IPO alternative gaining traction among high-profile private companies
  • The SPAC IPO phenomenon
  • Trends in
  • A fresh look at
  • Right-sizing incentive and employee purchase plans

The 2021 Venture Capital Report an in-depth US venture capital market review and outlook, including industry and regional breakdowns, as well as insights on the following topics:

  • Management carve-out plans as incentives in private company sales
  • Recent SEC rule amendments expanding the financing toolkit for pre-IPO companies
  • The importance of transfer pricing compliance for early-stage companies
  • Deal term trends in VC-backed company M&A transactions and convertible note, SAFE and venture capital financings

The 2021 M&A Report provides a global M&A market review and outlook, as well as insights on the following topics:

  • Takeover defenses for public companies
  • The impact of buy-side representation and warranty insurance on deal terms in private company sales
  • Recent SEC amendments providing financial statement disclosure relief for business acquisitions and dispositions
  • Steps boards can take to limit the impact of Delaware courts’ increasing openness to shareholder books and records demands
  • A comparison of deal terms in public and private company acquisitions
  • The challenges and potential benefits of pre-IPO acquisitions
  • Special considerations for parties doing M&A deals in California
  • Deal term trends in VC-backed company acquisitions

Each report also includes a center showcasing prominent recent transactions in each area and company counsel rankings from independent sources showing WilmerHale’s preeminence as counsel in IPOs, VC financings and sales of VC-backed companies.

See other News & Publications related to:

See related industries:

Life Sciences , Technology